The Drug-Induced Respiratory Disease Website
Publications
Welcome to the Real World: Understanding the Many Faces of Osimertinib-Related Pneumonitis.
Chest 2022 Nov;162;965-967 — 2022 Nov — 965-967
Sato Y, Sumikawa H, Shibaki R, Morimoto T, Sakata Y, Oya Y, Tamiya M, Suzuki H, Matsumoto H, Yokoi T, Hashimoto K, Kobe H, Hino A, Inaba M, Tsukita Y, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Sakata S, Fujimoto D
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World Setting.
Chest 2022 Nov;162;1188-1198 — 2022 Nov — 1188-1198
Osimertinib in Pulmonary Manifestations: Two Case Reports and Review of the Literature.
In vivo (Athens, Greece) 2020 Jan-Feb;34;315-319 — 2020 Jan-Feb — 315-319